Structural Basis for Highly Selective Class II Alpha Phosphoinositide-3-Kinase Inhibition

被引:0
|
作者
Kuecuekdisli, Murat [1 ]
Bel-Abed, Hassen [1 ]
Cirillo, Davide [1 ]
Lo, Wen-Ting [1 ]
Efrem, Nina-Louisa [1 ]
Horatscheck, Andre [1 ]
Perepelittchenko, Liudmila [1 ]
Prokofeva, Polina [2 ]
Ehret, Theresa A. L. [3 ,4 ]
Radetzki, Silke [1 ]
Neuenschwander, Martin [1 ]
Specker, Edgar [1 ]
Medard, Guillaume [2 ]
Mueller, Susanne [3 ,4 ]
Wilhelm, Stephanie [2 ]
Kuster, Bernhard [2 ]
von Kries, Jens Peter [1 ]
Haucke, Volker [1 ]
Nazare, Marc [1 ]
机构
[1] Leibniz Forschungsinst Mol Pharmakol FMP, Campus Berlin Buch, D-13125 Berlin, Germany
[2] Tech Univ Munich, Chair Prote & Bioanalyt, D-85354 Freising Weihenstephan, Germany
[3] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany
[4] Struct Genom Consortium SGC, Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany
关键词
IMPAIRS PROLIFERATION; ACUTE-LEUKEMIA; BRAIN-TUMORS; 3-KINASE; PI3K; PI3K-C2-ALPHA; MIGRATION; SURVIVAL; PATHWAY;
D O I
10.1021/acs.jmedchem.3c01319
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Class II phosphoinositide-3-kinases (PI3Ks) play central roles in cell signaling, division, migration, and survival. Despite evidence that all PI3K class II isoforms serve unique cellular functions, the lack of isoform-selective inhibitors severely hampers the systematic investigation of their potential relevance as pharmacological targets. Here, we report the structural evaluation and molecular determinants for selective PI3K-C2 alpha inhibition by a structure-activity relationship study based on a pteridinone scaffold, leading to the discovery of selective PI3K-C2 alpha inhibitors called PITCOINs. Cocrystal structures and docking experiments supported the rationalization of the structural determinants essential for inhibitor activity and high selectivity. Profiling of PITCOINs in a panel of more than 118 diverse kinases showed no off-target kinase inhibition. Notably, by addressing a selectivity pocket, PITCOIN4 showed nanomolar inhibition of PI3K-C2 alpha and >100-fold selectivity in a general kinase panel. Our study paves the way for the development of novel therapies for diseases related to PI3K-C2 alpha function.
引用
收藏
页码:14278 / 14302
页数:25
相关论文
共 50 条
  • [1] Ablation of phosphoinositide-3-kinase class II alpha suppresses hepatoma cell proliferation
    Ng, Stanley K. L.
    Neo, Soek-Ying
    Yap, Yann-Wan
    Karuturi, R. Krishna Murthy
    Loh, Evelyn S. L.
    Liau, Kui-Hin
    Ren, Ee-Chee
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (02) : 310 - 315
  • [2] Overexpression of phosphoinositide-3-kinase class II alpha enhances mesenchymal stem cell survival in infarcted myocardium
    Eun, Lucy Youngmin
    Song, Byeong-Wook
    Cha, Min-Ji
    Song, Heesang
    Kim, Il-Kwon
    Choi, Eunmi
    Chang, Woochul
    Lim, Soyeon
    Choi, Eun Ju
    Ham, Onju
    Lee, Se-Yeon
    Byun, Ki Hyun
    Jang, Yangsoo
    Hwang, Ki-Chul
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 402 (02) : 272 - 279
  • [3] Mutation of Phosphoinositide-3-Kinase Regulatory Subunit Alpha 1, Leading to Hyperactivation of Phosphoinositide-3-Kinase, Results in an Immunodeficiency Resembling APDS
    Parry, D. A.
    Maisuria, S.
    Argumugacani, G.
    Logan, C. V.
    Wood, P. M.
    Cant, A.
    Gooi, H. C.
    Johnson, C. A.
    Nejentsev, S.
    Doody, G.
    Savic, S.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 : S179 - S179
  • [4] Phosphoinositide-3-Kinase Inhibition Enhances Radiosensitization of Cervical Cancer In Vivo
    Liu, Yi
    Cui, Baoxia
    Qiao, Yunbo
    Zhang, Yan
    Tian, Yongju
    Jiang, Jie
    Ma, Daoxin
    Kong, Beihua
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (01) : 100 - 105
  • [5] Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibition
    Rossios, C.
    To, Y.
    Osoata, G.
    Ito, M.
    Barnes, P. J.
    Ito, K.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 167 (04) : 775 - 786
  • [6] Discovery and Characterization of a Potent and Selective Inhibitor for Human Phosphoinositide-3-kinase γ
    Meleza, Cesar
    Chen, Ada
    Fournier, Jeremy
    Mailyan, Artur
    Mata, Guillaume
    Jeffrey, Jenna
    Banuelos, Jesus
    Zhao, Xiaoning
    Leleti, Manmohan
    Jin, Lixia
    Powers, Jay
    Matthew, J.
    Young, Stephen
    FASEB JOURNAL, 2020, 34
  • [7] Structural Basis for Activation and Inhibition of Class I Phosphoinositide 3-Kinases
    Vadas, Oscar
    Burke, John E.
    Zhang, Xuxiao
    Berndt, Alex
    Williams, Roger L.
    SCIENCE SIGNALING, 2011, 4 (195)
  • [8] Inhibition of Phosphoinositide-3-Kinase Signaling Promotes the Stem Cell State of Trophoblast
    Lee, Cheryl Q. E.
    Bailey, Alexander
    Lopez-Tello, Jorge
    Sferruzzi-Perri, Amanda N.
    Okkenhaug, Klaus
    Moffett, Ashley
    Rossant, Janet
    Hemberger, Myriam
    STEM CELLS, 2019, 37 (10) : 1307 - 1318
  • [9] Phosphoinositide-3-Kinase Is the Primary Mediator of Phosphoinositide-Dependent Inhibition in Mammalian Olfactory Receptor Neurons
    Ukhanov, Kirill
    Corey, Elizabeth
    Ache, Barry W.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2016, 10
  • [10] Structural Basis for Isoform Selectivity in a Class of Benzothiazole Inhibitors of Phosphoinositide 3-Kinase γ
    Collier, Philip N.
    Martinez-Botella, Gabriel
    Cornebise, Mark
    Cottrell, Kevin M.
    Doran, John D.
    Griffith, James P.
    Mahajan, Sudipta
    Maltais, Francois
    Moody, Cameron S.
    Huck, Emilie Porter
    Wang, Tiansheng
    Aronov, Alex M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (01) : 517 - 521